Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

15.9K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
15.9K
Chemical Synapses01:26

Chemical Synapses

9.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.5K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

6.0K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
6.0K
Chemical Synapses01:26

Chemical Synapses

10.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A translational preclinical strategy for chronic spinal cord injury: neuroprotective and regenerative potential of botulinum neurotoxin type A combined with muscle atrophy prevention via electrostimulation.

Military Medical Research·2026
Same author

C-Terminal Nucleobase Modification Amplifies Peptide-Mediated Liposome Fusion.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Going Deep into the Surface Chemistry of Carbon Dots: Influence of Functional Groups on the Redox Abilities.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Enteric botulinum neurotoxins facilitate infection by <i>Salmonella</i> and <i>Shigella</i>.

Science advances·2026
Same author

Repairing the defective folding of alpha-sarcoglycan is needed to promote myogenic cell engraftment in 3D artificial muscle models of LGMDR3.

Skeletal muscle·2025
Same author

Alterations in peroxisome-mitochondria interplay in skeletal muscle accelerate muscle dysfunction.

Nature communications·2025

Related Experiment Video

Updated: May 3, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.0K

Presynaptic enzymatic neurotoxins.

Ornella Rossetto1, Laura Morbiato, Paola Caccin

  • 1Dipartimento di Scienze Biomediche and Istituto CNR di Neuroscienze, Università di Padova, Padova, Italy. ornella.rossetto@unipd.it

Journal of Neurochemistry
|June 30, 2006
PubMed
Summary

Botulinum neurotoxins and snake venom toxins inhibit nerve function by targeting nerve terminals. These toxins offer potential therapeutic applications for managing hyperactive nerve conditions.

More Related Videos

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

7.9K
Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

11.6K

Related Experiment Videos

Last Updated: May 3, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.0K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

7.9K
Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

11.6K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Toxicology

Background:

  • Botulinum neurotoxins (BoNTs), highly toxic proteins from Clostridium, cause botulism by cleaving neuroexocytosis proteins in nerve terminals, inhibiting neurotransmitter release.
  • These neurotoxins are therapeutically used for conditions involving hyperactive nerve terminals.
  • Snake presynaptic phospholipase A2 (PLA2) neurotoxins disrupt nerve terminal function by hydrolyzing phospholipids, altering membrane dynamics and neurotransmitter release.

Purpose of the Study:

  • To elucidate the mechanisms of action of botulinum neurotoxins and snake presynaptic PLA2 neurotoxins.
  • To explore the potential therapeutic applications of these neurotoxins and their byproducts.

Main Methods:

  • Analysis of the molecular mechanisms by which BoNTs inhibit neurotransmitter release.
  • Investigation of the effects of snake PLA2 neurotoxins on nerve terminal membrane structure and function.
  • Examination of phospholipid hydrolysis products (lysophospholipids and fatty acids) generated by PLA2.

Main Results:

  • Botulinum neurotoxins act as metalloproteinases, cleaving key proteins in the neuroexocytosis pathway.
  • Snake PLA2 neurotoxins induce both neurotransmitter release and subsequent inhibition of vesicle recycling through membrane alteration.
  • Lysophospholipids and fatty acids produced by PLA2 activity were identified as key mediators of these effects.

Conclusions:

  • Botulinum neurotoxins provide a model for understanding and treating conditions with excessive nerve activity.
  • Snake venom PLA2 neurotoxins offer insights into synaptic vesicle dynamics and neurotransmission.
  • The lysophospholipid/fatty acid mixture generated by PLA2 has potential for therapeutic use in inhibiting superficial hyperactive nerve terminals.